Cargando…
An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
Conditions presenting with signs of thrombotic microangiopathies (TMAs) comprise a wide spectrum of different diseases. While pathological hallmarks are thrombosis of arterioles and capillaries, clinical signs are mechanical haemolysis, thrombocytopenia and acute renal injury or neurological manifes...
Autores principales: | Aigner, Christof, Schmidt, Alice, Gaggl, Martina, Sunder-Plassmann, Gere |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543965/ https://www.ncbi.nlm.nih.gov/pubmed/31198225 http://dx.doi.org/10.1093/ckj/sfz040 |
Ejemplares similares
-
Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea
por: Brocklebank, Vicky, et al.
Publicado: (2017) -
Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab
por: Jin, Anna, et al.
Publicado: (2016) -
Relapsing thrombotic microangiopathy and intravenous sustained-release oxycodone
por: Nataatmadja, Melissa, et al.
Publicado: (2016) -
Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab
por: Allinovi, Marco, et al.
Publicado: (2017) -
Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2020)